{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Phase 2 Study of Tovorafenib (DAY101) in Relapsed and Refractory Langerhans Cell Histiocytosis","item":"https:\/\/www.regionalcancercare.org\/trials\/phase-2-study-of-tovorafenib-day101-in-relapsed-and-refractory-langerhans-cell-histiocytosis\/#breadcrumbitem"}]}